http://www.news.colostate.edu/Release/7483
The $2 million subcontract was awarded by Battelle Memorial Institute, a research organization that serves the DoD Medical Countermeasure Systems Joint Vaccine Acquisition Program (MCS-JVAP). Among MCS-JVAP’s requirements is to develop a vaccine to protect soldiers from aerosolized exposure to filoviruses, which cause several types of hemorrhagic fever.
BioMARC will make contributions toward furthering the development of a replicon vaccine platform containing a non-infectious Ebola antigen, which has been shown to protect nonhuman primates from an intramuscular and aerosol challenge with the Ebola virus.
Can the CDC and Scientists on Freerepublic please tell the government to quit wasting money on vaccines to protect against Aerosol transmissions of Ebola since it can’t possibly happen. No way. No how. Nothing to see here. Move On. NO AEROSOL TRANSMISSION POSSIBLE
Ahem...